Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an initial public offering (IPO) on the week of April 7th, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on the week of April 7th, IPO Scoop reports.

Panellists at the OBN BioTrinity 2025 conference in London discussed how US uncertainty is impacting the biopharma environment.

The maker of the FDA’s only approved total artificial heart has outlined plans to go public, with a $12 million IPO, ...

At least 63 biopharma layoff rounds were conducted in the first quarter of this year, with cell and gene biotechs accounting ...

CoreWeave, an artificial intelligence startup backed by Nvidia NVDA.O, has signed a five-year contract worth $11.9 billion with OpenAI to provide cloud computing services ahead of its hotly ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

Before Fadel Lawandy joined Chapman University, where he is the director of the C. Larry Hoag Center for Real Estate and Finance and director of the Janes Financial Center, he was a portfolio manager ...

A Schroders trust formerly run by star stockpicker Neil Woodford has upgraded the value of its stake in Revolut by 85 per ...

Drug development is coming back in vogue and this fund’s ‘full life cycle’ approach means it’s ready to capture the gains ...

The share acquisition is the latest twist in a dispute between Alcon and fellow Aurion shareholder Deerfield Management over ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Xeris ...